How several signaling pathways are coordinated to generate complex organs through regulation of tissue growth and patterning is a fundamental question in developmental biology. The larval trachea of Drosophila is composed of differentiated functional cells and groups of imaginal tracheoblasts that build the adult trachea during metamorphosis. Air sac primordium cells (ASP) are tracheal imaginal cells that form the dorsal air sacs that supply oxygen to the flight muscles of the Drosophila adult. The ASP emerges from the tracheal branch that connects to the wing disc by the activation of both Bnl-FGF/Btl and EGFR signaling pathways. Together, these pathways promote cell migration and proliferation. In this study we demonstrate that Vein (vn) is the EGF ligand responsible for the activation of the EGFR pathway in the ASP. We also find that the Bnl-FGF/Btl pathway regulates the expression of vn through the transcription factor PointedP2 (PntP2). Furthermore, we show that the FGF target gene escargot (esg) attenuates EGFR signaling at the tip cells of the developing ASP, reducing their mitotic rate to allow proper migration. Altogether, our results reveal a link between Bnl-FGF/Btl and EGFR signaling and provide novel insight into how the crosstalk of these pathways regulates migration and growth.
receptor Breathless (Btl) in the ASP cells. As the expression of Bnl in the wing disc changes, the ASP migrates and grows in direction of the source 1 . While Bnl/FGF signaling controls ASP migration, EGFR regulates cell proliferation and cell survival 1, 3 . Bnl/FGF signaling activity is restricted to the migrating tip cells, the cells of the distal/middle part of the ASP, where it activates the transcription of several genes, such as the transcription factor Esg and matrix metalloprotease Mmp2. While Esg is essential for tip cell identity, Mmp2 has two important functions in ASP development. Firstly, Mmp2 regulates the levels of Collagen IV and Perlecan in the extracellular matrix surrounding disc-associated trachea and ASP, in order to align juxtaposed tracheal and disc cells 4 . Secondly, it represses the activation of Bnl/FGF signaling in the stalk cells, the tracheoblasts of the proximal/middle part of ASP 5 . In contrast to Bnl/FGF signaling, the EGFR pathway is activated all along the ASP promoting cell proliferation. However, EGFR pathway seems to be activated to higher levels in the stalk/middle cells inducing more cell divisions in this specific region of the ASP 3 . Despite these studies, a number of important questions remain elusive: which ligand is responsible for EGFR activation? how it is related to restricted Bnl signaling? and how ASP migration and growth are globally coordinated?
Here we show that the Bnl/FGF pathway coordinates ASP growth by the activation of the EGF ligand Vn expression through the transcription factor Pointed (Pnt). Our genetic analysis reveal that Vn is the main EGF ligand in the stalk cells of the ASP, as silencing of vn abrogates the formation of this organ. In addition we find that the transcription factor esg, a FGF target gene, which is highly expressed at the tip cells, attenuates EGF signaling and thus cell proliferation in this region of the ASP. Importantly, this study reveals a link between Bnl/FGF and EGFR pathways during ASP development and provides new insight into how these signaling pathways coordinate to control cell migration and tissue growth.
Results
Vn is the EGFR ligand in the ASP. Drosophila has four EGFR ligands: Spitz (Spi), Keren (Krn), Gurken (Grk) and Vn. Vn is produced as a mature secreted protein, while the other three ligands require maturation by the protease Rhomboid (Rho) 6 . grk is a specific ligand of EGFR in oogenesis 7 and Krn has a minor role as homozygous Krn mutant flies are viable 8 . Therefore, to identify which of the Drosophila EGFR ligands is responsible for EGFR pathway activation in the ASP we disrupted spi and vn gene function in the tracheal system of third instar larvae. This was achieved by the expression of specific RNAi constructs for either gene, using the trachea-specific btlGal4 driver, and controlled temporally through the co-expression of a temperature-sensitive Gal80 ts suppressor. The efficacy of the RNAi-lines was validated in the wing disc where a typical EGFR loss of function phenotype can be easily observed ( Supplementary Fig. 1A-D) . Knockdown of spi had no effect on either adult wing 9 or ASP formation ( Supplementary Fig. 1A ,C). Consistent with this result, overexpression of Argos (Aos), which inhibits EGFR signaling 10 through the specific capturing of the Spi ligand 11 , also showed no phenotype in air sac development ( Supplementary Fig. 1D ). In addition, using an antibody against Spi and a rholacZ reporter strain as a read out of the activity of Spi, we did not detect any Spi protein, and only a very weak expression of rholacZ in the ASP ( Supplementary Fig. 1E,F) . In contrast, depletion of vn by RNAi produced a strong impairment in air sac formation ( Fig. 1A and Supplementary Fig. 1B) . Consistently, over-expression of vn specifically triggered a higher cell division rate, generating bulgy outgrowths, without perturbing air sac guidance (Fig. 1A, arrowhead) . These results strongly suggest that vn is the ligand responsible of the EGFR pathway activation during air sac development.
Next we checked the expression pattern of vn in the developing ASP. Immunostaining against β -galactosidase of vn-lacZ reporter and GFP expression under the control of vnGal4 revealed vn expression in the ASP cells (Fig. 1B and Supplementary Fig. 2 ). The expression of vn was already detected at early L3 in all tracheal cells of TC branch, when the ASP starts budding. As the ASP formed and migrated across the wing imaginal disc vn expression increased in those cells (Fig. 1B and Supplementary  Fig. 2 ), suggesting that vn expression is regulated in the ASP cells.
In addition to vn expression in the tracheal cells, vn was also detected in the wing disc cells adjacent to the ASP (arrowheads in Fig. 1B and Supplementary Fig. 2 ). Since Vn is a secreted protein, it might be that vn expression in the wing disc exerts an effect on the ASP in a non-autonomous manner. To assess this possibility we knocked down vn, using apterousGal4 driver, which is restricted in the dorsal compartment of the wing disc where the ASP forms. Interestingly, depletion of vn in the dorsal compartment of the wing disc had no effect on ASP development, proving that the specific expression of vn in the ASP is responsible for EGFR activation during the development of this structure ( Supplementary Fig. 1G ).
Vn promotes proliferation and cell survival during air sac development. The fact that the lack of vn strongly disrupted the formation of the ASP prompted us to investigate whether this phenotype is due to either an increase in cell death, or a reduction in cell proliferation. Under wild-type conditions proliferating ASP cells were detected using Phosphohistone-3 (PH3) a marker often used to identify dividing cells 12, 3 (Fig. A,A' ) whereas apoptosis was monitored by cleaved Caspase-3 staining, which was not detected (Fig. 2D,D' ). In contrast, expressing vn RNAi throughout the tracheal system using btlGal4 caused a drastic reduction specifically in the ASP, in proliferative cells (Fig. 2B,B' ) and an increase in cell death (Fig. 2E,E' ). This effect is specific of the ASP cells, as the other mitotic populations of the tracheal system are unaffected (Supplementary Fig. 3) . Consistently, over-expression of Vn in ASP tracheal cells using the same driver increased cell division (Fig. 2C,C' ) without affecting apoptosis (Fig. 2F,F' ). Interestingly, co-expression of vn RNAi and P35, a viral inhibitor of apoptosis 13 , in flip out clones increased the size of vn depleted clones ( Fig. 2G-I ) and partially restored the number of tracheoblasts in the ASP when co-expressed in all tracheal cells (Fig. 2J ). These results suggest that loss of tissue in the absence of vn is caused by both a reduction in cell proliferation and an increase in cell death, supporting the previously reported role of EGFR pathway in the growing ASP 3 . Thus, we conclude that Vn activates the EGFR pathway to sustain the rate of proliferation that normally takes place during ASP development and to maintain cell viability.
Bnl/FGF signaling activates Vein expression in the ASP. Ectopic activation of Bnl/FGF signaling causes a significant increase in the number of ASP tracheoblast cells 1 . However, a previous report suggested that the essential role of FGF signaling is to control directed organ extension via cell migration, whereas it is EGFR signaling that promotes cell proliferation 3 . Such observations prompted us Expression of vn using a vnlacZ enhancer trap in the ASP in early, mid and late L3 instar larva. In early L3, vnlacZ (red) was detected in the tracheal branch attached to the wing disc with higher levels at the tip of the incipient ASP (arrow). In mid L3 vn expression was even stronger among the tip/middle cells (arrow). Finally in late L3 instar expression of vn was more enriched in the stalk cells. Note that vn was also detected in the disc areas surrounding the ASP (arrowhead).
to hypothesize that Bnl/FGF signaling might regulate EGFR signaling by controlling the expression of vn in the ASP. To investigate this possibility, we ectopically expressed Bnl/FGF in the wing disc using dppgal4 driver. Under this condition, multiple tracheoblasts were generated and migrated over the wing disc epithelium along the region of bnl expression ( Fig. 3A and Supplementary Fig. 4A,B) . Interestingly, vn expression was detected in all ectopic tracheoblasts ( Fig. 3A and Supplementary Fig. 4A,B) suggesting that Bnl/FGF signaling controls vn expression in the ASP. Accordingly, similar results were obtained when over-expression clones of a constitutively activated form of Btl receptor (Torso-Btl/Fgfr) were generated in the ASP. Tracheoblasts with over-activated Bnl/FGF signaling expressed higher vn levels and therefore proliferated at a higher rate (Fig. 3B) . Similar over-proliferation phenotype was obtained when Bnl/FGF was expressed in all ASP cells ( Supplementary Fig. 4C,D) .
To confirm that the overgrowth produced by ectopic expression of the Btl receptor activated form was due to a vn up-regulation, we compared loss and gain of function mutant clones of EGFR signaling and Bnl-FGF/Btl signaling and measured the resulting clones volume. Compared with the control, both an EGFR dominant negative form and vn RNAi over-expression reduced clone size significantly ( Fig. 3C -E,I and Supplementary Fig. 5A-C) . In contrast, larger clones were observed after over-expression of either Torso-Btl/Fgfr or Vn protein (Fig. 3F,G,I and Supplementary Fig. 5E,F) . Finally, as expected, co-expression of Torso-Btl/Fgfr and vn RNAi reduced clone size to levels similar to control (Fig. 3H,I ). Thus, we conclude that Bnl-FGF/Btl signaling activates tracheoblast proliferation and acts to maintain cell viability by activating EGFR signaling through the regulation of vn expression.
Bnl-FGF/Btl signaling regulates vn expression via Pnt. To further understand how Bnl-FGF/Btl signaling regulates vn expression we investigated the role of Pnt, an ETS domain transcription factor that mediates Ras/Map kinase signaling 3, 14, 15 . The Drosophila pnt gene encodes two ETS proteins, PntP1 and PntP2, which are controlled by two distinct promoters 16 . PntP1 and PntP2 share a conserved C-terminal DNA-binding ETS domain but PntP2 contains an additional Sterile Alpha Motif (SAM)/PNT domain, which is phosphorylated by MAPK 15 . Consequently upon activation of the MAPK signaling cascade, PntP1 functions as a constitutively active transcription factor, whereas PntP2 protein induces transcription only when phosphorylated 15 . Interestingly, phosphorylated PntP2 binds directly to the vn regulatory region controlling its expression pattern in early wing development 17 . To test whether PntP2 and PntP1 also regulate vn expression in the ASP, we generated pnt knockdown clones in the ASP using two independent pnt RNAi lines that deplete both isoforms ( Supplementary Fig. 6 ). In pnt depleted cells vn expression was abolished (Fig. 4A,A' ) and consistently the formation of the ASP was prevented in a similar way to vn RNAi condition (Fig. 4E,F) . In addition, when pnt RNAi clones are generated in the ASP, we mainly recover only small sized clones (Supplementary Fig. 4D ). Next we checked the pnt expression pattern in the ASP. Using PntP1 and PntP2 specific lacZ reporter lines 14, 18 , we found that these isoforms show different expression patterns in the ASP. Whereas PntP1 presented a more enriched expression at the distal/middle region of the ASP (Fig. 4B,B' ; 19 ) PntP2 is expressed in all ASP cells (Fig. 4C,C' and Supplementary Fig. 7 ), suggesting distinct roles for Pnt isoforms in vn regulation. To confirm this possibility we ectopically expressed a specific inhibitor of PntP2, an ETS-domain lacking edl/mae 20 in all the ASP tracheal cells. Inhibition of PntP2 strongly impaired ASP development, although the cells still projected multiple filopodia (Fig. 4G, arrowheads) . Consistently, over-expression of a PntP2 activated form PntP2 VP16 21 , which should circumvent the need for upstream pathway components, significantly increased the size of ASP (Fig. 4H,L) . On the other hand, over-expression of PntP1 in the ASP blocks cell proliferation, probably by conferring migratory features on all tracheal cells (Fig. 4I,L) . Altogether, these data suggest that Bnl-FGF/Btl signaling controls cell migration of the ASP by the up-regulation of PntP1, and vn expression through PntP2.
FGF attenuates EGFR activity at the tip cells of the ASP. Although cell divisions in the ASP
occur in both the proximal and distal regions at similar rates, the central region of the sac presents twice the number of cells than the tip region 3 . A distinct activity of EGFR signaling in the central region versus the tip region might explain the difference in regional cell number. Since Bnl-FGF/Btl signaling is only activated at high levels in cells at the tip 3 it is reasonable to assume that this pathway might reduce the activity of EGFR in this region. To assess this possibility, using btlGal4/tubGal80 ts we ectopically expressed Esg in the tracheal system. Esg is a transcription factor regulated by Bnl-FGF/Btl signaling and mediates tip-cell-specific functions in the developing tracheal system 1, 5, 19, 22, 23 . Interestingly, this manipulation caused a dramatic reduction in cell number (Fig. 4J,L) . Conversely, esg silencing using esg RNAi under the control of btlGal4/tubGal80 ts , produced a significant increase in PH3 positive cells at the tip/ middle part of the ASP, thus expanding the cell number of this area and modifying the ASP morphology ( Fig. 4K and Supplementary Fig. 8B-D) . Altogether our results indicate that esg might alleviate EGFR signaling activity at the tip of the ASP. Nevertheless, our data do not discard completely the possibility that Esg could attenuate cell proliferation in an independent EGFR/Vn mechanism. Yet, we support the idea that Bnl-FGF/Btl signaling exerts a mitogen effect in the ASP by modulating the activity of EGFR signaling, activating the pathway through the up-regulation of its ligand Vn and attenuating it through the expression of the transcriptor factor Esg.
Discussion
Two receptor tyrosine-kinases (RTKs), Btl/FGFr and EGFR have been implicated in the control of ASP growth and migration along the underlying wing imaginal disc. While Bnl-FGF/Btl signaling is required for directional cell migration, EGFR signaling is needed for cell division and survival 3 . In this study we have identified the mechanism through which these two signaling pathways are coordinated to develop the functional ASP.
We identified Vn as the ligand responsible for the activation of EGFR signaling during ASP development, while the other EGFR ligands seem to play either no role, or only a residual one. We have also shown that Bnl-FGF/Btl signaling induces the expression of vn, as over-activation of the pathway produces overgrowth by up-regulating vn expression, and such overgrowth is reverted when vn is silenced (Fig. 3G,H) . Therefore we propose a model where Bnl-FGF/Btl signaling activates EGFR signaling by regulating vn expression (Fig. 4M) . However, high Bnl-FGF/Btl signaling occurs only at the tip of ASP 1, 3, 5 , whereas vn expression is detected in all ASP tracheal cells. How then, is vn expression maintained outside the Bnl-FGF/Btl domain? In the embryo and the wing disc vn is also a target of EGFR signaling through Pnt, forming a feedback loop that regulates EGFR signaling [24] [25] [26] . In the ASP a similar process might also apply for regulation of vn expression. Thus at early L3 Bnl-FGF/Btl signaling is activated in a subset of tracheal cells that up-regulate vn expression. As the growth of the ASP proceeds and the stalk cells move away from the Bnl-FGF/Btl activation domain, EGFR signaling might provide the input to maintain vn transcription in those cells in a positive feedback loop. Interestingly, a similar process has recently been reported in the wing disc where once initiated, vn expression is amplified and maintained by autocrine signaling mediated by PntP2
17
.This is consistent with our finding that vn induction in the ASP is mainly mediated by the transcription factor PntP2, which is likely through direct binding as multiple putative ETS binding sites have previously been identified in the vn promotor 17 . In addition, our analyses show that Pnt has an active role in proliferation since most pnt RNAi mutant clones generated in the ASP are very small (Supplementary Fig. 5D ). Interestingly, PntP2 is expressed in all ASP cells and specifically blocking this isoform in the ASP impairs cell proliferation but not cell migration, as tracheal cells still emit filopodia (Fig. 4G) . Moreover, over-expression of a specific PntP2 isoform induces a bigger ASP with more cells (Fig. 4H,L) . Consistently, the other isoform PntP1 is only expressed in the distal part of the ASP, and its over-expression blocks cell proliferation, most likely by conferring migratory features on all cells (Fig. 4I) . These differing functions of pnt isoforms could explain the different output of the activation of those two different RTKs in ASP. Thus, whereas both Bnl-FGF/Btl and EGFR signaling are able to activate PntP2 through its phosphorylation, only Bnl-FGF/Btl signaling is able to up-regulate the constitutive activator of transcription PntP1, which in turn activates genes involved in migration (Fig. 4M) . However, it has been shown that Pnt seems to be required only for cell migration but not for cell proliferation 3 . A possible explanation for such a discrepancy would be that the pnt alleles used in this study only partially eliminate PntP2, as previously suggested 27 . We also showed that up-regulation of vn activates EGFR signaling in all ASP cells, promoting cell division (Fig. 2C,C') . However, the number of cell divisions in the ASP is not homogenous, with twice as many in the central part in contrast to the most distal part. This observation suggested a possible regional restriction on EGFR activity 3 . In this regard we provide evidence that the transcription factor esg restricts the EGFR response in the tip cells. esg is induced exclusively in tracheal cells that receive FGF/Btl signal, giving those cells a tip-cell fate 1, 5, 19, 22, 23 . When esg is silenced the ASP has a more rounded shape, due to an increase in cell division in the tip cells, without affecting cell viability (Fig. 4K and Supplementary Fig. 5) . Consistently, ectopic expression of Esg increases the number of tip cells but reduces the total number of ASP cells 5 ( Fig. 4J,L) . This clearly suggests that Esg restricts EGFR signaling in the more distal cells by inducing tip-cell fate. In contrast, cells further away from the Bnl source either do not activate FGF/Btl signaling or activate the pathway at low levels, due to an Mmp2-mediated mechanism of lateral inhibition 5 . Consequently, there is either no, or low levels of transcription of esg in stalk/middle cells, allowing the full activation of EGFR signaling in the central part of the prospective air sac, and therefore enhancing cell division in this area (Fig. 4M) . Nevertheless, our experiments do not exclude the possibility that Esg could regulate cell proliferation at the tip of ASP through another unknown process. Further studies are required to discard such possibility.
ASP development resembles that of vertebrate organs in that cell proliferation and cell death are concomitant with branching morphogenesis. Therefore, it is likely that the signaling crosstalk described here for the Drosophila ASP is also used in other developmental processes, in a comparable way. Accordingly, a similar modulation of EGFR signaling has been seen in the development of other tubular structures, such as the Malpighian tubules. In this case Wg signaling activates the expression of rho in both the tip and sibling cell in order to produce the ligand Spi, which in turn promotes cell division and cell survival 28 . In lung development, branch outgrowth and elongation are associated with cell division. In this tissue the coordinated activity of signaling factors including Wnts and Fgf10 regulate proliferation [29] [30] [31] . In the mammary gland, FGF signaling stimulates cell proliferation and/or survival to generate cells both at the branching epithelium tips and cells in the subtending duct [32] [33] [34] . Whether this mitotic effect is directly mediated by FGF or through another signaling pathway is still unknown. However, although no link between FGF and EGFR in mammary gland has yet been reported, it is tempting to speculate that the regulatory interplay between such signaling pathways might also promote branching and growth in vertebrates. Future studies should address the relationship of these pathways in branching development.
